Napa BioMedical – Trademark Portfolio
Entity Type: 03
Napa BioMedical holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include N3 LABORATORIES and NEUROVATIONS A PATIENT CARE & INNOVATION COMPANY. The owner is based in Napa, CA.
3434 Villa Lane Suite 150
3434 Villa Lane Suite 150
Napa, CA 94558
Showing of trademarks Trademarks
Trademark Classifications
Napa BioMedical's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Napa BioMedical have?
Napa BioMedical has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.
What trademark classes does Napa BioMedical file in?
Napa BioMedical files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Napa BioMedical's most well-known trademarks?
Napa BioMedical's registered trademark portfolio includes well-known marks such as N3 LABORATORIES and NEUROVATIONS A PATIENT CARE & INNOVATION COMPANY. These are among 2 currently registered trademarks in the portfolio.
What is Napa BioMedical's trademark registration success rate?
Napa BioMedical has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.